• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短篇交流:氟卡尼通过增加触发活动的阈值对儿茶酚胺多形性室性心动过速的小鼠模型发挥抗心律失常作用。

Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.

机构信息

Cardiovascular Genetics Program, Leon H. Charney Division of Cardiology, New York University School of Medicine, 522 First Ave, New York, NY 10016, USA.

出版信息

Circ Res. 2011 Jul 22;109(3):291-5. doi: 10.1161/CIRCRESAHA.111.247338. Epub 2011 Jun 16.

DOI:10.1161/CIRCRESAHA.111.247338
PMID:21680895
Abstract

RATIONALE

Flecainide prevents arrhythmias in catecholaminergic polymorphic ventricular tachycardia, but the antiarrhythmic mechanism remains unresolved. It is possible for flecainide to directly affect the cardiac ryanodine receptor (RyR2); however, an extracellular site of action is suggested because of the hydrophilic nature of flecainide.

OBJECTIVE

To investigate the mechanism for the antiarrhythmic action of flecainide in a RyR2(R4496C+/-) knock-in mouse model of catecholaminergic polymorphic ventricular tachycardia.

METHODS AND RESULTS

Flecainide prevented catecholamine-induced sustained ventricular tachycardia in RyR2(R4496C+/-) mice. Cellular studies were performed with isolated RyR2(R4496C+/-) myocytes. Isoproterenol caused the appearance of spontaneous Ca(2+) transients, which were unaffected by flecainide (6 μmol/L). Flecainide did not affect Ca(2+) transient amplitude, decay, or sarcoplasmic reticulum Ca(2+) content. Moreover, it did not affect the frequency of spontaneous Ca(2+) sparks in permeabilized myocytes. In contrast, flecainide effectively prevented triggered activity induced by isoproterenol. The threshold for action potential induction was increased significantly (P<0.01), which suggests a primary extracellular antiarrhythmic effect mediated by Na(+) channel blockade.

CONCLUSIONS

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in RyR2(R4496C+/-) mice; however, at variance with previous reports, we observed minimal effects on intracellular Ca(2+) homeostasis. Our data suggest that the antiarrhythmic activity of the drug is caused by reduction of Na(+) channel availability and by an increase in the threshold for triggered activity.

摘要

原理

氟卡尼可预防儿茶酚胺多形性室性心动过速中的心律失常,但抗心律失常机制仍未解决。氟卡尼可能直接影响心脏兰尼碱受体(RyR2);然而,由于氟卡尼的亲水性,提示其作用部位在细胞外。

目的

在儿茶酚胺多形性室性心动过速的 RyR2(R4496C+/-)基因敲入小鼠模型中研究氟卡尼的抗心律失常作用机制。

方法和结果

氟卡尼可预防 RyR2(R4496C+/-)小鼠儿茶酚胺诱导的持续性室性心动过速。用分离的 RyR2(R4496C+/-)肌细胞进行细胞研究。异丙肾上腺素引起自发性 Ca(2+)瞬变的出现,氟卡尼(6μmol/L)对其无影响。氟卡尼不影响 Ca(2+)瞬变幅度、衰减或肌浆网 Ca(2+)含量。此外,它不影响通透肌细胞中自发性 Ca(2+)火花的频率。相比之下,氟卡尼可有效预防异丙肾上腺素诱导的触发活动。动作电位诱导的阈值显著增加(P<0.01),这表明存在由 Na(+)通道阻断介导的主要细胞外抗心律失常作用。

结论

氟卡尼可预防 RyR2(R4496C+/-)小鼠儿茶酚胺多形性室性心动过速;然而,与先前的报道不同,我们观察到细胞内 Ca(2+)稳态的影响最小。我们的数据表明,药物的抗心律失常活性是通过减少 Na(+)通道的可利用性和增加触发活动的阈值引起的。

相似文献

1
Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.短篇交流:氟卡尼通过增加触发活动的阈值对儿茶酚胺多形性室性心动过速的小鼠模型发挥抗心律失常作用。
Circ Res. 2011 Jul 22;109(3):291-5. doi: 10.1161/CIRCRESAHA.111.247338. Epub 2011 Jun 16.
2
RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.RYR2 通道抑制是氟卡尼在 CPVT 中作用的主要机制。
Circ Res. 2021 Feb 5;128(3):321-331. doi: 10.1161/CIRCRESAHA.120.316819. Epub 2020 Dec 10.
3
Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺敏感性多形性室性心动过速小鼠模型中舒张期 Ca(2+)释放增加和窦房结活性降低的矛盾现象。
Circulation. 2012 Jul 24;126(4):392-401. doi: 10.1161/CIRCULATIONAHA.111.075382. Epub 2012 Jun 18.
4
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.肌浆网磷蛋白敲除可阻断致心律失常性 Ca²⁺波并抑制小鼠儿茶酚胺敏感性多形性室性心动过速。
Circ Res. 2013 Aug 16;113(5):517-26. doi: 10.1161/CIRCRESAHA.113.301678. Epub 2013 Jul 15.
5
The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.氟卡尼在 CPVT 中的作用机制不涉及对 RyR2 的直接作用。
Circ Res. 2015 Apr 10;116(8):1324-35. doi: 10.1161/CIRCRESAHA.116.305347. Epub 2015 Feb 3.
6
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.抑制心脏 Ca2+ 释放通道 (RyR2) 可决定 I 类抗心律失常药物在儿茶酚胺多形性室性心动过速中的疗效。
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):128-35. doi: 10.1161/CIRCEP.110.959916. Epub 2011 Jan 26.
7
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.兰尼碱受体突变体RyR2R4496C的钙敏感性增加是儿茶酚胺能多形性室性心动过速的基础。
Circ Res. 2009 Jan 30;104(2):201-9, 12p following 209. doi: 10.1161/CIRCRESAHA.108.177493. Epub 2008 Dec 18.
8
In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.在完整心脏中的共聚焦成像揭示了 2 型兰尼碱受体(R4496C+/-)突变型儿茶酚胺多形性室性心动过速小鼠模型中应激诱导的 Ca(2+)释放变异性。
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):841-9. doi: 10.1161/CIRCEP.111.969733. Epub 2012 Jun 21.
9
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.钠依赖性肌质网 Ca2+ 超载可导致携有人 CPVT 突变的小鼠心肌细胞发生致心律失常事件。
Cardiovasc Res. 2010 Jul 1;87(1):50-9. doi: 10.1093/cvr/cvq007. Epub 2010 Jan 15.
10
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.钙释放通道蛋白 2 突变致儿茶酚胺敏感性多形性室性心动过速小鼠模型中心律失常和钙稳态失衡的预防。
J Cardiovasc Electrophysiol. 2011 Mar;22(3):316-24. doi: 10.1111/j.1540-8167.2010.01877.x. Epub 2010 Aug 30.

引用本文的文献

1
Simultaneous optical recording of action potentials and calcium transients in cardiac single cells differentiated from type 1 CPVT-iPS cells.对源自1型儿茶酚胺敏感性多形性室性心动过速诱导多能干细胞(CPVT-iPS细胞)分化而来的心脏单细胞中的动作电位和钙瞬变进行同步光学记录。
Front Physiol. 2025 Jun 4;16:1579815. doi: 10.3389/fphys.2025.1579815. eCollection 2025.
2
Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.小儿氟卡尼药物基因组学:为小儿心律失常提供精准医疗的路线图。
Front Pharmacol. 2024 Dec 16;15:1477485. doi: 10.3389/fphar.2024.1477485. eCollection 2024.
3
Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies.
儿茶酚胺能多形性室性心动过速:临床特征、诊断评估与治疗策略
J Clin Med. 2024 Mar 20;13(6):1781. doi: 10.3390/jcm13061781.
4
The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.自主神经系统的促心律失常作用以及预防心脏离子通道病猝死的新兴神经调节方法。
Cardiovasc Res. 2024 Mar 13;120(2):114-131. doi: 10.1093/cvr/cvae009.
5
Catecholaminergic Polymorphic Ventricular Tachycardia and Gene Therapy: A Comprehensive Review of the Literature.儿茶酚胺能多形性室性心动过速与基因治疗:文献综述
Cureus. 2023 Oct 30;15(10):e47974. doi: 10.7759/cureus.47974. eCollection 2023 Oct.
6
Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia.探讨氟卡尼在儿茶酚胺多形性室性心动过速中的作用机制。
J Med Life. 2023 Aug;16(8):1294-1296. doi: 10.25122/jml-2023-0191.
7
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.氟卡尼与儿茶酚胺多形性室性心动过速大患者队列中心律失常事件发生率较低相关。
Circulation. 2023 Dec 19;148(25):2029-2037. doi: 10.1161/CIRCULATIONAHA.123.064786. Epub 2023 Oct 27.
8
Canine Model of Ischemia-Induced Ventricular Tachycardia.缺血性室性心动过速犬模型。
J Surg Res. 2024 Jan;293:196-203. doi: 10.1016/j.jss.2023.09.003. Epub 2023 Sep 29.
9
Sex and Gene Influence Arrhythmia Susceptibility in Murine Models of Calmodulinopathy.钙调蛋白病小鼠模型的性别和基因对心律失常易感性的影响。
Circ Arrhythm Electrophysiol. 2023 Sep;16(9):e010891. doi: 10.1161/CIRCEP.122.010891. Epub 2023 Aug 17.
10
Autonomic control of ventricular function in health and disease: current state of the art.自主神经对心室功能在健康和疾病中的控制:当前的最新技术。
Clin Auton Res. 2023 Aug;33(4):491-517. doi: 10.1007/s10286-023-00948-8. Epub 2023 May 11.